Clinical Trials in Salt Lake City

Showing 7441-7460 of 12,670 trials

Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery

NCT03212365

Plastic and reconstructive surgeons consistently create large, raw surfaces as part of their operative procedures. Thus, plastic \& reconstructive surgery patients are among those at highest risk for anticoagulant-associated bleeding adverse drug events (ADEs). This study seeks to optimize both the safety and effectiveness of post-operative enoxaparin by comparing aFXa levels, bleeding events, and VTE events among plastic \& reconstructive surgery patients randomized to receive two different enoxaparin dose regimens.

Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolus+1 more

University of Utah295 participantsStarted Jul 2017

Stanford, California, United States • Salt Lake City, Utah, United States

COMPLETEDPhase 2< 1 mile

A Study of TRV130 for the Treatment of Pain After Bunionectomy

NCT02100748

The primary objective is to evaluate the analgesic efficacy of IV TRV130 compared with placebo in patients with acute postoperative pain after bunionectomy.

Acute Pain

Trevena Inc.333 participantsStarted Apr 2014

Phoenix, Arizona, United States • Pasadena, Maryland, United States • Austin, Texas, United States +1 more locations

WITHDRAWNNA< 1 mile

Comparison of Quantitative MRI Perfusion Methods With Quantitative PET Perfusion Imaging

NCT02608944

This work seeks to develop, evaluate and use new MRI methods for non-invasive quantitative assessment of myocardial perfusion and perfusion reserve (MPR), and to compare with quantitative PET imaging.

MRI Scans

University of UtahStarted Sep 2012

Salt Lake City, Utah, United States

Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery

A Study of TRV130 for the Treatment of Pain After Bunionectomy

Comparison of Quantitative MRI Perfusion Methods With Quantitative PET Perfusion Imaging

Find Trials by Condition in Salt Lake City

Oral Iron for Erythropoietic Protoporphyrias

Clinical Evaluation of Flortaucipir F 18

Dose Finding Study to Treat High Phosphate Levels in the Blood.

A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH

A Study of Tucatinib (ONT-380) Combined With Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2+ Breast Cancer

A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer

PROMINENT-Eye Ancillary Study (Protocol AD)

A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer

Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer

A Study to Assess Resistance and Durability of Response to ABT-493 and/or ABT-530

Study to Evaluate the Efficacy and Safety of Andecaliximab Combined With Nivolumab Versus Nivolumab Alone in Adults With Unresectable or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma

Multidimensional System to Dynamically Predict Graft Survival After Kidney Transplantation

A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma

Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma

Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis

A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001